1. Home
  2. CLRB vs GIGM Comparison

CLRB vs GIGM Comparison

Compare CLRB & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • GIGM
  • Stock Information
  • Founded
  • CLRB 2002
  • GIGM 1998
  • Country
  • CLRB United States
  • GIGM Taiwan
  • Employees
  • CLRB N/A
  • GIGM N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • GIGM Computer Software: Programming Data Processing
  • Sector
  • CLRB Health Care
  • GIGM Technology
  • Exchange
  • CLRB Nasdaq
  • GIGM Nasdaq
  • Market Cap
  • CLRB 17.5M
  • GIGM 20.2M
  • IPO Year
  • CLRB N/A
  • GIGM 2000
  • Fundamental
  • Price
  • CLRB $4.97
  • GIGM $1.64
  • Analyst Decision
  • CLRB Hold
  • GIGM
  • Analyst Count
  • CLRB 2
  • GIGM 0
  • Target Price
  • CLRB N/A
  • GIGM N/A
  • AVG Volume (30 Days)
  • CLRB 110.6K
  • GIGM 12.4K
  • Earning Date
  • CLRB 11-17-2025
  • GIGM 10-29-2025
  • Dividend Yield
  • CLRB N/A
  • GIGM N/A
  • EPS Growth
  • CLRB N/A
  • GIGM N/A
  • EPS
  • CLRB N/A
  • GIGM N/A
  • Revenue
  • CLRB N/A
  • GIGM $3,250,000.00
  • Revenue This Year
  • CLRB N/A
  • GIGM N/A
  • Revenue Next Year
  • CLRB N/A
  • GIGM N/A
  • P/E Ratio
  • CLRB N/A
  • GIGM N/A
  • Revenue Growth
  • CLRB N/A
  • GIGM N/A
  • 52 Week Low
  • CLRB $4.11
  • GIGM $1.34
  • 52 Week High
  • CLRB $66.00
  • GIGM $1.89
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 45.44
  • GIGM 47.63
  • Support Level
  • CLRB $4.56
  • GIGM $1.62
  • Resistance Level
  • CLRB $4.98
  • GIGM $1.66
  • Average True Range (ATR)
  • CLRB 0.35
  • GIGM 0.05
  • MACD
  • CLRB -0.13
  • GIGM -0.02
  • Stochastic Oscillator
  • CLRB 18.11
  • GIGM 36.29

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About GIGM GigaMedia Limited

GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.

Share on Social Networks: